1. Zhao W., Zhong Zh., Xie Х., Yu Q., Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. Am. J. Roentgenol. 2020; 214: 1072–1077. http://doi.org/10.2214/AJR.20.22976
2. Hosseiny M., Kooraki S., Gholamrezanehad A., Reddy S., Myers L. Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and Middle East respiratory syndrome. Am. J. Roentgenol. 2020;214:1078–1082.
3. Hosseiny M., Kooraki S., Gholamrezanezhad A., Reddy S., Lee M. Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. Am. J. Roentgenol. 2020;214:1078–1082. http://doi.org/10.2214/AJR.20.22969
4. Guan W., Liu J., Yu Ch. CT Findings of Coronavirus Disease (COVID-19) Severe Pneumonia. Am. J. Roentgenol. 2020; 214:W85–W86. http://doi.org/10.2214/AJR.20.23035
5. Huang G., Gong T., Wang G., Wang J., Guo X., Cai E., Li S., Li X., Yu Y., Lin L. Timely Diagnosis and Treatment Shortens the Time to Resolution of Coronavirus Disease (COVID-19) Pneumonia and Lowers the Highest and Last CT Scores From Sequential Chest CT. Am. J. Roentgenol. 2020; 215: 1–7. http://doi.org/10.2214/AJR.20.23078
6. Zhao W., Zheng Z., Xie X., Qizhi Y., Liu J. CT scans of patients with 2019 novel coronavirus (COVID-19) pneumonia. Theranostics. 2020; 10: 4606–4613. https://doi.org/10.7150/thno.45016
7. Hope M.D., Raptis C.A., Shah A. A role for CT in COVID-19? What data really tell us so far. Lancet. 2020; 395:1189– 1190. https://doi.org/10.1016/s0140-6736(20)30728-5
8. Сперанская А.А., Новикова Л.Н., Баранова О.П., Василь ева М.А. Лучевая диагностика вирусной пневмонии. Вестник рентгенологии и радиологии. 2016; 97 (3): 149–156. http://doi.org/10.20862/0042-4676-2016-97-3-149-156
9. Росстальная А.Л., Сабиров Д.М., Акалаев Р.Н., Шарипова В.Х., Росстальная М.Л., Мамиров А.О. Острое повреждение легких: спорные вопросы и нерешенные проблемы (обзор литературы). Журнал им. Н.В. Склифосовского “Неотложная медицинская помощь”. 2016; 3: 66–72.
10. Cardinal-Fernández P., Lorente J. A., Ballén-Barragán A., Matute-Bello G. Acute Respiratory Distress Syndrome and Diffuse Alveolar Damage. New Insights on a Complex Relationship. Ann. Am. Thorac. Soc. 2017; 14 (6): 844– 850. http://doi.org/10.1513/annalsats.201609-728ps
11. Khilnani GC, Hadda V. Corticosteroids and ARDS: A review of treatment and prevention evidence. Lung India. 2011; 28 (2): 114–119. http://doi.org/10.4103/0970-2113.80324
12. Mitchell O.J.L., Sternschein R., Kunzler N., Zhao Y., Uppal A. Acute Interstitial Pneumonia Versus Acute Respiratory Distress Syndrome: Is There a Difference? American Journal of Respiratory and Critical Care Medicine 2020;201:A5884
13. Cordier J.F. Organising pneumonia. Thorax. 2000; 55 (4): 318–328 http://doi.org/10.1136/thorax.55.4.318
14. Авдеев С.Н., Черняев А.Л. Организующаяся пневмония. Атмосфера. Пульмонология и аллергология. 2011; 1: 6–13.
15. Beasley M. The pathologist’s approach to acute lung injury. Arch. Pathol. Lab. Med. 2010; 134 (5): 719–727. http://doi.org/10.1043/1543-2165-134.5.719
16. Hwang D.M., Chamberlain D.W., Poutanen S.M., Low D.E., Asa S.L., Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod. Pathol. 2005; 18 (1): 1–10. https://doi.org/10.1038/modpathol.3800247
17. Copin M., Parmentier E., Duburcq T. et al. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med. Published online: 23 April 2020. https://doi.org/10.1007/s00134-020-06057-8
18. Kim J., Doo K., Jang H. Acute fibrinous and organizing pneumonia: Imaging features, pathologic correlation, and brief literature review. Radiol Case Rep. 2018; 13 (4): 867–870. http://doi.org/10.1016/j.radcr.2018.04.028
19. Самсонова М.В., Черняев А.Л., Михалева Л.М., Зайратьянц О.В., Мишнев О.Д. Патологическая анатомия легких при COVID-19. http://www.patolog.ru/sites/default/files/mv_samsonova_covid-19_.pdf
20. Lee N., Allen C., Hui D. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J. Clin. Virol. 2004; 31 (4): 304–309. http://doi.org/10.1016/j.jcv.2004.07.006
21. Wang Y, Jiang W, He Q, Wang C, Wang B, Zhou P et al. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct. Target Ther. 2020; 5 (1): 57. http://doi.org/10.1038/s41392-020-0158-2
22. Zhou Y., Qin Y., Lu Y. Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: protocol of a randomized controlled trial. Chin. Med. J. (Engl). 2020; 133 (9): 1080–1086. http://doi.org/10.1097/CM9.0000000000000791
23. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA. Intern Med. 2020 Mar 13: e200994. http://doi.org/10.1001/jamainternmed.2020.0994.
24. Fadel R., Morrison A., Vahia A., Smith Z., Chaudhry Z., Bhargava P. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19. COVID-19 Management Task Force. medRxiv 2020.05.04.20074609. https://doi.org/10.1101/2020.05.04.20074609
25. EVMS Critical Care COVID-19 Management Protocol 05-14-2020 | evms.edu/covidcare (EVMS COVID website: https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf